Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Gallbladder Neoplasms and CDKN2A[original query] |
---|
Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine. JCO precision oncology 2020 9 3 . Mondaca Sebastian, Razavi Pedram, Xu Chongrui, Offin Michael, Myers Mackenzie, Scaltriti Maurizio, Hechtman Jaclyn F, Bradley Mikaela, O'Reilly Eileen M, Berger Michael F, Solit David B, Li Bob T, Abou-Alfa Ghassan |
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies. Frontiers in oncology 2020 5 10 536. Wang Shuhang, Chen Rongrong, Tang Yu, Yu Yue, Fang Yuan, Huang Huiyao, Wu Dawei, Fang Hong, Bai Ying, Sun Chao, Yu Anqi, Fan Qi, Gu Dejian, Yi Xin, Li Ni |
Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: